Stay updated with breaking news from Patrickr Oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday. IONS has been the subject of a number of other reports. Needham & Company LLC reaffirmed a “buy” rating and set a […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one […]
StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. A number of other equities research analysts have also recently commented on the company. Royal Bank of Canada reissued an outperform rating and issued a $65.00 price objective […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday. A number of other brokerages also recently issued reports on IONS. Stifel Nicolaus increased their price objective on Ionis Pharmaceuticals from $45.00 to $50.00 and […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Patrick R. O’neil sold 20,825 shares of the business’s stock in a transaction dated Tuesday, December 26th. The stock was sold at an average price of $51.46, for a total value of $1,071,654.50. Following the transaction, the executive vice president now owns 40,355 shares of the […]